Table 1 Patient characteristics
From: Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study
N (%)* | Median | IQR (range) | ||
|---|---|---|---|---|
Age – years | 32 | 23-47 (13–76) | ||
Duration of trip – months (n = 66) | 1 | 0.8-3 (0.1-19) | ||
Weight – kg (n = 43) | 72 | 66-89 (52–104) | ||
Male Gender | 105 (69.5) | |||
Reason for travel | Business | 47 (31.1) | ||
Tourist | 30 (19.9) | |||
VFR^ | 28 (18.5) | |||
Migrant | 18 (11.9) | |||
Foreign visitors | 10 (6.6) | |||
Not Stated | 18 (11.9) | |||
Geographic region visited | Oceania | 115 (76.2%) | ||
Indian subcontinent | 14 (9.3%) | |||
SE Asia | 11 (7.3%) | |||
Africa | 6 (4.0%) | |||
S. America | 2 (1.3%) | |||
Multiple | 2 (1.3%) | |||
Unknown | 1 (0.7%) | |||
Chemoprophylaxis | Yes | 64 (42.4) | ||
No | 77 (51.0) | |||
Not recorded | 10 (6.6) | |||
Chemoprophylaxis agent (n = 64) | Doxycycline | 39 (60.9) | ||
Chloroquine | 6 (9.4) | |||
Mefloquine | 5 (7.8) | |||
Atovaquone/proguanil | 2 (3.1) | |||
Sulphadoxine/pyrimethamine | 1 (1.6) | |||
Combination of agents | 2 (3.1) | |||
Agent not known | 9 (14.0) | |||
Mixed infection | P. falciparum | 10 (6.6) | ||
P. malariae | 1 (0.6) | |||
Treatment (n = 179) | Chloroquine | 115 (64.2) | ||
Artemether/lumefantrine | 12 (6.7) | |||
Quinine+doxycycline | 7 (3.9) | |||
Mefloquine | 5 (2.8) | |||
Artesunate | 1 (0.6) | |||
Atovaquone/proguanil | 1 (0.6) | |||
Combination | 11 (6.1) | |||
Change in regimen | 18 (10.5) | |||
Unknown | 9 (5.0) |